Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib. The aim of this study was to evaluate whether concomitant treatment with conventional synthetic disease‐modifying antirheumatic d...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Arthritis Rheumatol
Главные авторы: Winthrop, Kevin L., Curtis, Jeffrey R., Lindsey, Stephen, Tanaka, Yoshiya, Yamaoka, Kunihiro, Valdez, Hernan, Hirose, Tomohiro, Nduaka, Chudy I., Wang, Lisy, Mendelsohn, Alan M., Fan, Haiyun, Chen, Connie, Bananis, Eustratios
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2017
Предметы:
Rheumatoid Arthritis
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656820/
https://ncbi.nlm.nih.gov/pubmed/28845604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40189
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы